Ignite Creation Date:
2024-05-05 @ 11:57 AM
Last Modification Date:
2024-10-26 @ 9:17 AM
Study NCT ID:
NCT00192244
Status:
COMPLETED
Last Update Posted:
2006-10-03
First Post:
2005-09-12
Brief Title:
Trial to Determine the Safety and Efficacy of Influenza Virus Vaccine Trivalent Types A B Live Cold-Adapted CAIV-T in Healthy Children
Sponsor:
MedImmune LLC
Organization:
MedImmune LLC
Study Overview
Official Title:
A Prospective Randomized Double-Blind Placebo-Controlled Trial to Determine the Safety and Efficacy of Influenza Virus Vaccine Trivalent Types A B Live Cold-Adapted CAIV-T in Healthy Children
Status:
COMPLETED
Status Verified Date:
2006-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
- The purpose of this study is to determine the efficacy of CAIV-T in a diverse Asian population aged from 6 months to less than 36 months in tropical and temperate climates against culture-confirmed influenza illness In addition the trial provides the opportunity to investigate the efficacy of CAIV-T over multiple influenza seasons and to investigate the effect of CAIV-T on acute otitis media
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None